The partnership gives Emervax an exclusive licence to use Kindeva’s solid-coated microneedle array patch for its emxRNA platform. Using circular RNA (circRNA) technology, an approach that ...

D. Boral Capital initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $14 price target Medicus is a development-stage ...

SINGAPORE, March 26, 2025 /PRNewswire/ -- Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds are marked by persistent ...